• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双能CT定量三维碘映射在鉴别胸腺上皮肿瘤中的应用价值

Usefulness of Three-Dimensional Iodine Mapping Quantified by Dual-Energy CT for Differentiating Thymic Epithelial Tumors.

作者信息

Doi Shuhei, Yanagawa Masahiro, Matsui Takahiro, Hata Akinori, Kikuchi Noriko, Yoshida Yuriko, Yamagata Kazuki, Ninomiya Keisuke, Kido Shoji, Tomiyama Noriyuki

机构信息

Department of Radiology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-City 565-0871, Osaka, Japan.

Department of Pathology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-City 565-0871, Osaka, Japan.

出版信息

J Clin Med. 2023 Aug 28;12(17):5610. doi: 10.3390/jcm12175610.

DOI:10.3390/jcm12175610
PMID:37685677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10488564/
Abstract

: Dual-energy CT has been reported to be useful for differentiating thymic epithelial tumors. The purpose is to evaluate thymic epithelial tumors by using three-dimensional (3D) iodine density histogram texture analysis on dual-energy CT and to investigate the association of extracellular volume fraction (ECV) with the fibrosis of thymic carcinoma. : 42 patients with low-risk thymoma ( = 20), high-risk thymoma ( = 16), and thymic carcinoma ( = 6) were scanned by dual-energy CT. 3D iodine density histogram texture analysis was performed for each nodule on iodine density mapping: Seven texture features (max, min, median, average, standard deviation [SD], skewness, and kurtosis) were obtained. The iodine effect (average on DECT180s-average on unenhanced DECT) and ECV on DECT180s were measured. Tissue fibrosis was subjectively rated by one pathologist on a three-point grade. These quantitative data obtained by examining associations with thymic carcinoma and high-risk thymoma were analyzed with univariate and multivariate logistic regression models (LRMs). The area under the curve (AUC) was calculated by the receiver operating characteristic curves. values < 0.05 were significant. : The multivariate LRM showed that ECV > 21.47% in DECT180s could predict thymic carcinoma (odds ratio [OR], 11.4; 95% confidence interval [CI], 1.18-109; = 0.035). Diagnostic performance was as follows: Sensitivity, 83.3%; specificity, 69.4%; AUC, 0.76. In high-risk thymoma vs. low-risk thymoma, the multivariate LRM showed that the iodine effect ≤1.31 mg/cc could predict high-risk thymoma (OR, 7; 95% CI, 1.02-39.1; = 0.027). Diagnostic performance was as follows: Sensitivity, 87.5%; specificity, 50%; AUC, 0.69. Tissue fibrosis significantly correlated with thymic carcinoma ( = 0.026). : ECV on DECT180s related to fibrosis may predict thymic carcinoma from thymic epithelial tumors, and the iodine effect on DECT180s may predict high-risk thymoma from thymoma.

摘要

据报道,双能量CT有助于鉴别胸腺上皮肿瘤。目的是利用双能量CT的三维(3D)碘密度直方图纹理分析评估胸腺上皮肿瘤,并研究细胞外体积分数(ECV)与胸腺癌纤维化的相关性。42例低危胸腺瘤(n = 20)、高危胸腺瘤(n = 16)和胸腺癌(n = 6)患者接受了双能量CT扫描。对碘密度图上的每个结节进行3D碘密度直方图纹理分析:获得七个纹理特征(最大值、最小值、中位数、平均值、标准差[SD]、偏度和峰度)。测量碘效应(DECT180s上的平均值减去未增强DECT上的平均值)和DECT180s上的ECV。由一名病理学家对组织纤维化进行主观的三分制评分。通过单变量和多变量逻辑回归模型(LRM)分析这些与胸腺癌和高危胸腺瘤相关性的定量数据。通过受试者工作特征曲线计算曲线下面积(AUC)。P值<0.05具有显著性。多变量LRM显示,DECT180s上ECV>21.47%可预测胸腺癌(优势比[OR],11.4;95%置信区间[CI],1.18 - 109;P = 0.035)。诊断性能如下:敏感性,83.3%;特异性,69.4%;AUC,0.76。在高危胸腺瘤与低危胸腺瘤的比较中,多变量LRM显示碘效应≤1.31 mg/cc可预测高危胸腺瘤(OR,7;95% CI,1.02 - 39.1;P = 0.027)。诊断性能如下:敏感性,87.5%;特异性,50%;AUC,0.69。组织纤维化与胸腺癌显著相关(P = 0.026)。DECT180s上与纤维化相关的ECV可能有助于从胸腺上皮肿瘤中预测胸腺癌,而DECT180s上的碘效应可能有助于从胸腺瘤中预测高危胸腺瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c5/10488564/e31a60e1c777/jcm-12-05610-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c5/10488564/093b3bc47dca/jcm-12-05610-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c5/10488564/4a64a5fb03de/jcm-12-05610-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c5/10488564/25f8dda41a2f/jcm-12-05610-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c5/10488564/e31a60e1c777/jcm-12-05610-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c5/10488564/093b3bc47dca/jcm-12-05610-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c5/10488564/4a64a5fb03de/jcm-12-05610-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c5/10488564/25f8dda41a2f/jcm-12-05610-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c5/10488564/e31a60e1c777/jcm-12-05610-g004a.jpg

相似文献

1
Usefulness of Three-Dimensional Iodine Mapping Quantified by Dual-Energy CT for Differentiating Thymic Epithelial Tumors.双能CT定量三维碘映射在鉴别胸腺上皮肿瘤中的应用价值
J Clin Med. 2023 Aug 28;12(17):5610. doi: 10.3390/jcm12175610.
2
Feasibility of iodine concentration and extracellular volume fraction measurement derived from the equilibrium phase dual-energy CT for differentiating thymic epithelial tumors.基于平衡期双能 CT 碘浓度和细胞外容积分数测量鉴别胸腺瘤的可行性。
Jpn J Radiol. 2023 Jan;41(1):45-53. doi: 10.1007/s11604-022-01331-9. Epub 2022 Aug 27.
3
Three-dimensional iodine mapping quantified by dual-energy CT for predicting programmed death-ligand 1 expression in invasive pulmonary adenocarcinoma.双能 CT 三维碘图定量预测浸润性肺腺癌程序性死亡配体 1 的表达。
Sci Rep. 2024 Aug 7;14(1):18310. doi: 10.1038/s41598-024-69470-9.
4
Iodine Quantification Using Dual-Energy Computed Tomography for Differentiating Thymic Tumors.使用双能计算机断层扫描进行碘定量以鉴别胸腺肿瘤
J Comput Assist Tomogr. 2018 Nov/Dec;42(6):873-880. doi: 10.1097/RCT.0000000000000800.
5
Multiparametric Evaluation of Radiomics Features and Dual-Energy CT Iodine Maps for Discrimination and Outcome Prediction of Thymic Masses.基于放射组学特征和双能量 CT 碘图的多参数评估在胸腺肿块鉴别诊断及预后预测中的价值
Acad Radiol. 2023 Dec;30(12):3010-3021. doi: 10.1016/j.acra.2023.03.034. Epub 2023 Apr 25.
6
CT-based radiomics analysis for differentiation between thymoma and thymic carcinoma.基于CT的放射组学分析用于胸腺瘤与胸腺癌的鉴别诊断。
J Thorac Dis. 2022 May;14(5):1342-1352. doi: 10.21037/jtd-21-1948.
7
Volume-based quantification using dual-energy computed tomography in the differentiation of thymic epithelial tumours: an initial experience.基于容积的双能计算机断层扫描在胸腺上皮肿瘤鉴别诊断中的应用:初步经验
Eur Radiol. 2017 May;27(5):1992-2001. doi: 10.1007/s00330-016-4542-9. Epub 2016 Aug 23.
8
Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters.多期双能 CT 评估肝纤维化:碘摄取参数的诊断性能。
Eur Radiol. 2021 Aug;31(8):5779-5790. doi: 10.1007/s00330-021-07706-2. Epub 2021 Mar 25.
9
CT texture analysis in evaluation of thymic tumors and thymic hyperplasia: correlation with the international thymic malignancy interest group (ITMIG) stage and WHO grade.CT 纹理分析在胸腺瘤和胸腺增生评估中的应用:与国际胸腺癌兴趣组(ITMIG)分期和 WHO 分级的相关性。
Br J Radiol. 2021 Dec;94(1128):20210583. doi: 10.1259/bjr.20210583. Epub 2021 Oct 5.
10
Extracellular volume fraction derived from equilibrium contrast-enhanced CT as a diagnostic parameter in anterior mediastinal tumors.从平衡对比增强 CT 得出的细胞外容积分数作为前纵隔肿瘤的诊断参数。
Eur J Radiol. 2023 Aug;165:110891. doi: 10.1016/j.ejrad.2023.110891. Epub 2023 May 23.

引用本文的文献

1
Development and validation of a model based on preoperative dual-layer detector spectral computed tomography 3D VOI-based quantitative parameters to predict high Ki-67 proliferation index in pancreatic ductal adenocarcinoma.基于术前双层探测器光谱计算机断层扫描基于3D VOI的定量参数预测胰腺导管腺癌高Ki-67增殖指数模型的开发与验证
Insights Imaging. 2024 Dec 5;15(1):291. doi: 10.1186/s13244-024-01864-9.

本文引用的文献

1
Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancer.利用对比增强计算机断层扫描通过细胞外体积分数评估胰腺纤维化及其与胰腺癌的关系
Eur J Radiol. 2022 Nov;156:110522. doi: 10.1016/j.ejrad.2022.110522. Epub 2022 Sep 11.
2
CT-based radiomics analysis for differentiation between thymoma and thymic carcinoma.基于CT的放射组学分析用于胸腺瘤与胸腺癌的鉴别诊断。
J Thorac Dis. 2022 May;14(5):1342-1352. doi: 10.21037/jtd-21-1948.
3
Spectral Photon-Counting Computed Tomography: A Review on Technical Principles and Clinical Applications.
光谱光子计数计算机断层扫描:技术原理与临床应用综述
J Imaging. 2022 Apr 15;8(4):112. doi: 10.3390/jimaging8040112.
4
Imaging Evaluation of Thymoma and Thymic Carcinoma.胸腺瘤和胸腺癌的影像学评估
Front Oncol. 2022 Jan 3;11:810419. doi: 10.3389/fonc.2021.810419. eCollection 2021.
5
CT imaging-based machine learning model: a potential modality for predicting low-risk and high-risk groups of thymoma: "Impact of surgical modality choice".基于 CT 成像的机器学习模型:预测胸腺瘤低危和高危人群的一种潜在方法:“手术方式选择的影响”。
World J Surg Oncol. 2021 May 11;19(1):147. doi: 10.1186/s12957-021-02259-6.
6
Hepatic fibrosis grading with extracellular volume fraction from iodine mapping in spectral liver CT.利用光谱肝脏 CT 中的碘映射进行肝纤维化分级和细胞外体积分数评估。
Eur J Radiol. 2021 Apr;137:109604. doi: 10.1016/j.ejrad.2021.109604. Epub 2021 Feb 16.
7
Thymic epithelial tumors: Do we know all the prognostic factors?胸腺上皮肿瘤:我们是否了解所有的预后因素?
Thorac Cancer. 2021 Feb;12(3):339-348. doi: 10.1111/1759-7714.13750. Epub 2021 Jan 2.
8
Extracellular volume fraction measurement correlates with lymphocyte abundance in thymic epithelial tumors.细胞外容积分数测量与胸腺癌上皮肿瘤中的淋巴细胞丰度相关。
Cancer Imaging. 2020 Oct 7;20(1):71. doi: 10.1186/s40644-020-00349-4.
9
MRI Radiomics Analysis for Predicting the Pathologic Classification and TNM Staging of Thymic Epithelial Tumors: A Pilot Study.MRI 影像组学分析预测胸腺癌的病理分级和 TNM 分期:一项初步研究。
AJR Am J Roentgenol. 2020 Feb;214(2):328-340. doi: 10.2214/AJR.19.21696. Epub 2019 Dec 4.
10
Systemic treatments for thymoma and thymic carcinoma: A systematic review.胸腺瘤和胸腺癌的系统治疗:系统评价。
Lung Cancer. 2018 Dec;126:25-31. doi: 10.1016/j.lungcan.2018.10.018. Epub 2018 Oct 18.